146 related articles for article (PubMed ID: 8712120)
1. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).
Devereux RB; Dahlof B; Levy D; Pfeffer MA
Am J Cardiol; 1996 Jul; 78(1):61-5. PubMed ID: 8712120
[TBL] [Abstract][Full Text] [Related]
2. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
4. [The effect of hypotensive drugs on left ventricular mass and diastolic function].
Spring A; Haczyński J; Jołda-Mydłowska B; Witkowska M
Pol Arch Med Wewn; 1995 Jul; 94(1):47-58. PubMed ID: 8524699
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
6. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy after treatment of hypertension: comparison of directed M-echocardiography with magnetic resonance imaging in quantification of serial mass changes.
Tse HF; Cheung BM; Ng W; Chan JK; Devereux RB; Lau CP
J Card Fail; 2003 Apr; 9(2):122-7. PubMed ID: 12751133
[TBL] [Abstract][Full Text] [Related]
8. [A reduction of left ventricular hypertrophy and an improvement in diastolic function after therapy with nifedipine retard in patients with hypertensive cardiopathy].
Amici E; Patruno N; Natale E; Marsocci A; Gambelli G
Cardiologia; 1993 Sep; 38(9):585-91. PubMed ID: 8287388
[TBL] [Abstract][Full Text] [Related]
9. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.
González-Juanatey JR; Pose Reino A; Román AV; García Acuña JM; Fernández López JA; Cerrato JC
Am J Cardiol; 1997 Feb; 79(3):373-6. PubMed ID: 9036764
[TBL] [Abstract][Full Text] [Related]
10. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
[TBL] [Abstract][Full Text] [Related]
11. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
González-Juanatey JR; Reino AP; García-Acuña JM; Varela Román A; Calvo Gómez C; Cabezas-Cerrato J
Am J Cardiol; 1998 Jan; 81(1):87-90. PubMed ID: 9462614
[TBL] [Abstract][Full Text] [Related]
12. Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression.
Cohen A; Bregman B; Agabiti Rosei E; Williams B; Dubourg O; Clairefond P; Brudi P; Gosse P; Guéret P
J Hum Hypertens; 1998 Jul; 12(7):479-83. PubMed ID: 9702935
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C
J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
[TBL] [Abstract][Full Text] [Related]
14. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
15. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
Dahlöf B; Hansson L
J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nifedipine GITS and hydrochlorothiazide in the management of elderly patients with stage I-III diastolic hypertension.
Dey HM; Soufer R; Hoffer P; Wackers FJ; Black HR
Am J Hypertens; 1996 Jun; 9(6):598-606. PubMed ID: 8783785
[TBL] [Abstract][Full Text] [Related]
17. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
18. Changes in left ventricular geometry during antihypertensive treatment.
Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
[TBL] [Abstract][Full Text] [Related]
19. Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.
Oki T; Fukuda N; Iuchi A; Tabata T; Sasaki M; Kawahara K; Ishimoto T; Tominaga T; Okushi H; Fujimoto T; Ito S
J Card Fail; 1995 Dec; 1(5):365-70. PubMed ID: 12836711
[TBL] [Abstract][Full Text] [Related]
20. [Management of hypertensive patients with left ventricular hypertrophy].
Ambrosioni E
Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
